Kyle A Emmitte

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

ACS chemical neuroscience

Bioengineering (Basel, Switzerland)

University of North Texas Health Science Center

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Texas Health Science Center

United States

Associate Professor of Pharmaceutical Sciences :: UNT System College of Pharmacy

Vanderbilt University Medical Center

United States

Research Assistant Professor/Assoc. Director of Medicinal Chemistry :: Vanderbilt Center for Neuroscience Drug Discovery

GlaxoSmithKline USA

United States

Project Team Leader :: Oncology Medicinal Chemistry

Education History

University of North Carolina at Chapel Hill

United States

PHD :: Chemistry

Texas A&M University

United States

BSC :: Chemistry

Publications

Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Alshaima'a M Qunies, Brittany D Spitznagel, Yu Du, Paul K Peprah, Yasmeen K Mohamed, C David Weaver, Kyle A Emmitte
Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Molecules (Basel, Switzerland) 29 (11) (2024)
Corinna Schüß, Oanh Vu, Nigam M Mishra, Iain R Tough, Yu Du, Jan Stichel, Helen M Cox, C David Weaver, Jens Meiler, Kyle A Emmitte, Annette G Beck-Sickinger
Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y 4 Receptor Positive Allosteric Modulator VU0506013. Journal of medicinal chemistry (2023)
Tina B McKay, Kyle A Emmitte, Carrie German, Dimitrios Karamichos
Quercetin and Related Analogs as Therapeutics to Promote Tissue Repair. Bioengineering (Basel, Switzerland) 10 (10) (2023)
Alshaima'a M Qunies, Kyle A Emmitte
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. Pharmaceutical patent analyst 11 (2) (2022)
Corinna Schüß, Oanh Vu, Mario Schubert, Yu Du, Nigam M Mishra, Iain R Tough, Jan Stichel, C David Weaver, Kyle A Emmitte, Helen M Cox, Jens Meiler, Annette G Beck-Sickinger
Highly Selective Y4 Receptor Antagonist Binds in an Allosteric Binding Pocket. Journal of medicinal chemistry 64 (5) (2021)
Brittany D Spitznagel, Nigam M Mishra, Alshaima'a M Qunies, Francis J Prael, Yu Du, Krystian A Kozek, Roman M Lazarenko, Jerod S Denton, Kyle A Emmitte, C David Weaver
VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons. ACS chemical neuroscience 11 (21) (2020)
Julie L Engers, Aaron M Bender, Jacob J Kalbfleisch, Hyekyung P Cho, Kaelyn S Lingenfelter, Vincent B Luscombe, Changho Han, Bruce J Melancon, Anna L Blobaum, Jonathan W Dickerson, Jerri M Rook, Colleen M Niswender, Kyle A Emmitte, P Jeffrey Conn, Dennis C Liotta
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M1 Positive Allosteric Modulators. ACS chemical neuroscience 10 (3) (2018)
Elizabeth S Childress, Joshua M Wieting, Andrew S Felts, Megan M Breiner, Madeline F Long, Vincent B Luscombe, Alice L Rodriguez, Hyekyung P Cho, Anna L Blobaum, Colleen M Niswender, Kyle A Emmitte, P Jeffrey Conn, Dennis C Liotta
Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide Cores. Journal of medicinal chemistry 62 (1) (2018)
Andrew S Felts, Alice L Rodriguez, Anna L Blobaum, Ryan D Morrison, Brittney S Bates, Analisa Thompson Gray, Jerri M Rook, Mohammed N Tantawy, Frank W Byers, Sichen Chang, Daryl F Venable, Vincent B Luscombe, Gilles D Tamagnan, Colleen M Niswender, J Scott Daniels, Carrie K Jones, P Jeffrey Conn, Dennis C Liotta, Kyle A Emmitte
Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation. Journal of medicinal chemistry 60 (12) (2017)

Kyle A Emmitte.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kyle A Emmitte